{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T23:26:28Z","timestamp":1782429988941,"version":"3.54.5"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T00:00:00Z","timestamp":1622160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Osteolysis resulting from osteoclast overactivation is one of the severe complications of breast cancer metastasis to the bone. Previous studies reported that the anti-cancer agent DZNep induces cancer cell apoptosis by activating Akt signaling. However, the effect of DZNep on breast cancer bone metastasis is unknown. We previously found that DZNep enhances osteoclast differentiation by activating Akt. Therefore, we explored the use of the anti-cancer agent AZD3463 (an Akt inhibitor) along with DZNep, as AZD3463 can act as an anti-cancer agent and can also potentially ameliorate bone erosion. We evaluated osteoclast and breast cancer cell phenotypes and Akt signaling <jats:italic>in vitro<\/jats:italic> by treating cells with DZNep and AZD3463. Furthermore, we developed a breast cancer bone metastasis animal model in mouse tibiae to further determine their combined effects <jats:italic>in vivo<\/jats:italic>. Treatment of osteoclast precursor cells with DZNep alone increased osteoclast differentiation, bone resorption, and expression of osteoclast-specific genes. These effects were ameliorated by AZD3463. The combination of DZNep and AZD3463 inhibited breast cancer cell proliferation, colony formation, migration, and invasion. Finally, intraperitoneal injection of DZNep and AZD3463 ameliorated tumor progression and protected against bone loss. In summary, DZNep combined with AZD3463 prevented skeletal complications and inhibited breast cancer progression by suppressing Akt signaling.<\/jats:p>","DOI":"10.3389\/fphar.2021.652071","type":"journal-article","created":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T07:55:52Z","timestamp":1622188552000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Combination of AZD3463 and DZNep Prevents Bone Metastasis of Breast Cancer by Suppressing Akt Signaling"],"prefix":"10.3389","volume":"12","author":[{"given":"Wenxin","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiankun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kewei","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.2174\/1871520620666200721121517","article-title":"Combination of Salinomycin and AZD3463 Reveals Synergistic Effect on Reducing the Viability of T98G Glioblastoma Cells","volume":"20","author":"Asik","year":"2020","journal-title":"Acamc"},{"key":"B2","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","article-title":"Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor","volume":"96","author":"Brunet","year":"1999","journal-title":"Cell"},{"key":"B3","doi-asserted-by":"publisher","first-page":"30399","DOI":"10.1074\/jbc.M113.469973","article-title":"Critical Role of AKT Protein in Myeloma-Induced Osteoclast Formation and Osteolysis","volume":"288","author":"Cao","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/bjc.2011.551","article-title":"The Role of EZH2 in Tumour Progression","volume":"106","author":"Chang","year":"2012","journal-title":"Br. J. Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"4988","DOI":"10.1016\/s0021-9258(18)42928-6","article-title":"Activation of Collagen IV Gene Expression in F9 Teratocarcinoma Cells by 3-deazaadenosine Analogs. Indirect Inhibitors of Methylation","volume":"267","author":"Chiang","year":"1992","journal-title":"J. Biol. Chem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/0006-2952(79)90642-7","article-title":"Perturbation of Biochemical Transmethylations by 3-deazaadenosine In Vivo","volume":"28","author":"Chiang","year":"1979","journal-title":"Biochem. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1093\/carcin\/bgr171","article-title":"(-)-Epigallocatechin-3-gallate and DZNep Reduce Polycomb Protein Level via a Proteasome-dependent Mechanism in Skin Cancer Cells","volume":"32","author":"Choudhury","year":"2011","journal-title":"Carcinogenesis"},{"key":"B8","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/B978-0-323-47674-4.00056-6","article-title":"Bone Metastases","volume-title":"Abeloff\u2019s Clinical Oncology","author":"Coleman","year":"2020"},{"key":"B9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10549-018-4697-y","article-title":"Targeting the PI3K\/AKT\/mTOR Pathway in Triple-Negative Breast Cancer: a Review","volume":"169","author":"Costa","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"B10","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1200\/JCO.2017.74.7352","article-title":"Cabozantinib, a New Standard of Care for Patients with Advanced Renal Cell Carcinoma and Bone Metastases? Subgroup Analysis of the METEOR Trial","volume":"36","author":"Escudier","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1182\/blood-2009-03-213496","article-title":"Combined Epigenetic Therapy with the Histone Methyltransferase EZH2 Inhibitor 3-deazaneplanocin A and the Histone Deacetylase Inhibitor Panobinostat against Human AML Cells","volume":"114","author":"Fiskus","year":"2009","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13148-016-0226-1","article-title":"Polycomb Repressive Complex\u2019s Evolutionary Conserved Function: the Role of EZH2 Status and Cellular Background","volume":"8","author":"Gall Tro\u0161elj","year":"2016","journal-title":"Clin. Epigenetics"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e98176","DOI":"10.1371\/journal.pone.0098176","article-title":"3-Deazaneplanocin A (DZNep), an Inhibitor of the Histone Methyltransferase EZH2, Induces Apoptosis and Reduces Cell Migration in Chondrosarcoma Cells","volume":"9","author":"Girard","year":"2014","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/0006-291X(86)90048-3","article-title":"3-Deazaneplanocin: A New and Potent Inhibitor of S-Adenosylhomocysteine Hydrolase and its Effects on Human Promyelocytic Leukemia Cell Line HL-60","volume":"135","author":"Glazer","year":"","journal-title":"Biochem. Biophysical Res. Commun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.1016\/0006-2952(86)90774-4","article-title":"3-deazaneplanocin A: A New Inhibitor of S-Adenosylhomocysteine Synthesis and its Effects in Human colon Carcinoma Cells","volume":"35","author":"Glazer","year":"","journal-title":"Biochem. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.bbrc.2020.10.058","article-title":"Temozolomide Treatment Combined with AZD3463 Shows Synergistic Effect in Glioblastoma Cells","volume":"533","author":"Goker Bagca","year":"2020","journal-title":"Biochem. Biophysical Res. Commun."},{"key":"B17","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s10555-016-9637-x","article-title":"PI3K\/AKT\/mTOR: Role in Breast Cancer Progression, Drug Resistance, and Treatment","volume":"35","author":"Guerrero-Zotano","year":"2016","journal-title":"Cancer Metastasis Rev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.critrevonc.2013.05.015","article-title":"Bone Effects of Mammalian Target of Rapamycin (mTOR) Inhibition with Everolimus","volume":"87","author":"Hadji","year":"2013","journal-title":"Crit. Rev. Oncology\/Hematology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10549-010-0982-0","article-title":"S-Adenosylhomocysteine Hydrolase Inhibition by 3-deazaneplanocin A Analogues Induces Anti-cancer Effects in Breast Cancer Cell Lines and Synergy with Both Histone Deacetylase and HER2 Inhibition","volume":"127","author":"Hayden","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"B20","doi-asserted-by":"publisher","first-page":"6393","DOI":"10.1158\/0008-5472.CAN-12-2664","article-title":"p38 MAPK in Myeloma Cells Regulates Osteoclast and Osteoblast Activity and Induces Bone Destruction","volume":"72","author":"He","year":"2012","journal-title":"Cancer Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1096\/fj.201600748R","article-title":"EZH2 Deletion in Early Mesenchyme Compromises Postnatal Bone Microarchitecture and Structural Integrity and Accelerates Remodeling","volume":"31","author":"Hemming","year":"2017","journal-title":"FASEB j."},{"key":"B22","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.neo.2015.01.005","article-title":"Everolimus Plus Exemestane for the Treatment of Advanced Breast Cancer: A Review of Subanalyses from BOLERO-2","volume":"17","author":"Hortobagyi","year":"2015","journal-title":"Neoplasia"},{"key":"B23","doi-asserted-by":"publisher","first-page":"336","DOI":"10.21037\/atm.2020.02.110","article-title":"AZD3463, an IGF-1R Inhibitor, Suppresses Breast Cancer Metastasis to Bone via Modulation of the PI3K-Akt Pathway","volume":"8","author":"Hu","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.bbrc.2006.10.011","article-title":"Induction of C-Fos and NFATc1 during RANKL-Stimulated Osteoclast Differentiation Is Mediated by the P38 Signaling Pathway","volume":"351","author":"Huang","year":"2006","journal-title":"Biochem. Biophysical Res. Commun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3816\/CBC.2010.n.059","article-title":"The Cathepsin K Inhibitor Odanacatib Suppresses Bone Resorption in Women with Breast Cancer and Established Bone Metastases: Results of a 4-week, Double-Blind, Randomized, Controlled Trial","volume":"10","author":"Jensen","year":"2010","journal-title":"Clin. Breast Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"11606","DOI":"10.1073\/pnas.1933744100","article-title":"EZH2 Is a Marker of Aggressive Breast Cancer and Promotes Neoplastic Transformation of Breast Epithelial Cells","volume":"100","author":"Kleer","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/19328","article-title":"Direct Control of the Forkhead Transcription Factor AFX by Protein Kinase B","volume":"398","author":"Kops","year":"1999","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/PPO.0b013e318281e280","article-title":"Targeting MET and Vascular Endothelial Growth Factor Receptor Signaling in Castration-Resistant Prostate Cancer","volume":"19","author":"Lee","year":"2013","journal-title":"Cancer J. (United States"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1210\/endo.143.8.8954","article-title":"p38 MAPK-Mediated Signals Are Required for Inducing Osteoclast Differentiation but Not for Osteoclast Function","volume":"143","author":"Li","year":"2002","journal-title":"Endocrinology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s00432-019-02950-y","article-title":"Targeting Cathepsin K Diminishes Prostate Cancer Establishment and Growth in Murine Bone","volume":"145","author":"Liang","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0166-3542(92)90083-H","article-title":"Rational Approaches to the Design of Antiviral Agents Based on S-Adenosyl-L-Homocysteine Hydrolase as a Molecular Target","volume":"19","author":"Liu","year":"1992","journal-title":"Antiviral Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s11914-012-0109-0","article-title":"Signaling Pathways Affecting Skeletal Health","volume":"10","author":"Marie","year":"2012","journal-title":"Curr. Osteoporos. Rep."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41408-018-0169-1","article-title":"The ALK Inhibitor AZD3463 Effectively Inhibits Growth of Sorafenib-Resistant Acute Myeloid Leukemia","volume":"9","author":"Moharram","year":"2019","journal-title":"Blood Cancer J."},{"key":"B34","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4049\/jimmunol.1101254","article-title":"Akt Induces Osteoclast Differentiation through Regulating the GSK3\u03b2\/NFATc1 Signaling Cascade","volume":"188","author":"Moon","year":"2012","journal-title":"J.I."},{"key":"B35","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/1476-4598-9-151","article-title":"Polycomb Repressor Complex 2 Regulates HOXA9 and HOXA10, Activating ID2 in NK\/T-cell Lines","volume":"9","author":"Nagel","year":"2010","journal-title":"Mol. Cancer"},{"key":"B36","doi-asserted-by":"publisher","first-page":"118643","DOI":"10.1016\/j.lfs.2020.118643","article-title":"Effects of Rapamycin and AZD3463 Combination on Apoptosis, Autophagy, and Cell Cycle for Resistance Control in Breast Cancer","volume":"264","author":"Ozates","year":"2021","journal-title":"Life Sci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1021\/acs.nanolett.9b02916","article-title":"Metal-Organic Framework Nanoparticles for Ameliorating Breast Cancer-Associated Osteolysis","volume":"20","author":"Pang","year":"2020","journal-title":"Nano Lett."},{"key":"B37","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/sj.bjc.6600126","article-title":"Activation of Akt\/PKB in Breast Cancer Predicts a Worse Outcome Among Endocrine Treated Patients","volume":"86","author":"P\u00e9rez-Tenorio","year":"2002","journal-title":"Br. J. Cancer"},{"key":"B38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2217\/fon.10.157","article-title":"Epigenetic Factors in Cancer Development: Polycomb Group Proteins","volume":"7","author":"Piunti","year":"2011","journal-title":"Future Oncol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/bcr2354","article-title":"BRCA1-deficient Mammary Tumor Cells Are Dependent on EZH2 Expression and Sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A","volume":"11","author":"Puppe","year":"2009","journal-title":"Breast Cancer Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e0142704","DOI":"10.1371\/journal.pone.0142704","article-title":"Vorinostat Enhances Cytotoxicity of SN-38 and Temozolomide in ewing Sarcoma Cells and Activates STAT3\/AKT\/MAPK Pathways","volume":"10","author":"Sampson","year":"2015","journal-title":"PLoS One"},{"key":"B41","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1200\/JCO.2012.45.0494","article-title":"Cabozantinib in Patients with Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation Trial","volume":"31","author":"Smith","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1200\/JCO.2015.65.5597","article-title":"Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1","volume":"34","author":"Smith","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00223-017-0353-5","article-title":"Bone-Targeted Therapies in Cancer-Induced Bone Disease","volume":"102","author":"Sousa","year":"2018","journal-title":"Calcif. Tissue Int."},{"key":"B44","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S1097-2765(04)00211-4","article-title":"The IGF-1\/PI3K\/Akt Pathway Prevents Expression of Muscle Atrophy-Induced Ubiquitin Ligases by Inhibiting FOXO Transcription Factors","volume":"14","author":"Stitt","year":"2004","journal-title":"Mol. Cel"},{"key":"B45","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1074\/jbc.M410480200","article-title":"Akt1\/Akt2 and Mammalian Target of rapamycin\/Bim Play Critical Roles in Osteoclast Differentiation and Survival, Respectively, whereas Akt Is Dispensable for Cell Survival in Isolated Osteoclast Precursors","volume":"280","author":"Sugatani","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B46","doi-asserted-by":"publisher","first-page":"9211","DOI":"10.1158\/0008-5472.CAN-09-1622","article-title":"EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance","volume":"69","author":"Suv\u00e0","year":"2009","journal-title":"Cancer Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1101\/gad.1524107","article-title":"Pharmacologic Disruption of Polycomb-Repressive Complex 2-mediated Gene Repression Selectively Induces Apoptosis in Cancer Cells","volume":"21","author":"Tan","year":"2007","journal-title":"Genes Dev."},{"key":"B48","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.job.2019.07.002","article-title":"Regulation of Osteoclast Function via Rho-Pkn3-C-Src Pathways","volume":"61","author":"Uehara","year":"2019","journal-title":"J. Oral Biosci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep19423","article-title":"Novel ALK Inhibitor AZD3463 Inhibits Neuroblastoma Growth by Overcoming Crizotinib Resistance and Inducing Apoptosis","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e21583","DOI":"10.1371\/journal.pone.0021583","article-title":"Determinants of Sensitivity to DZNep Induced Apoptosis in Multiple Myeloma Cells","volume":"6","author":"Xie","year":"2011","journal-title":"PLoS One"},{"key":"B51","doi-asserted-by":"publisher","first-page":"59","DOI":"10.7150\/ijbs.8.59","article-title":"EZH2 Methyltransferase and H3K27 Methylation in Breast Cancer","volume":"8","author":"Yoo","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-018-0349-8","article-title":"DZNep Inhibits H3K27me3 Deposition and Delays Retinal Degeneration in the Rd1 Mice","volume":"9","author":"Zheng","year":"2018","journal-title":"Cell Death Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41401-020-00543-x","article-title":"EZH2 Regulates Expression of FOXC1 by Mediating H3K27me3 in Breast Cancers","author":"Zheng","year":"2020","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.652071\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T07:55:55Z","timestamp":1622188555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.652071\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,28]]},"references-count":54,"alternative-id":["10.3389\/fphar.2021.652071"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.652071","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,28]]},"article-number":"652071"}}